|Bid||0.00 x 800|
|Ask||72.24 x 800|
|Day's range||71.43 - 74.98|
|52-week range||63.92 - 88.78|
|Beta (5Y monthly)||0.66|
|PE ratio (TTM)||77.35|
|Forward dividend & yield||0.21 (0.27%)|
|Ex-dividend date||03 May 2022|
|1y target est||N/A|
Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.
Henry Schein's (HSIC) Q2 performance will likely reflect continued strength in its dental and medical businesses.
IDEXX's (IDXX) Q2 performance will likely benefit from strong sales from the CAG Diagnostics and Water businesses.